A new study among female BRCA1 and BRCA2 (BRCA1/2) carriers after breast cancer found that they had a 16-fold higher risk of anaplastic large-cell lymphoma associated with breast implants. This occurred in BRCA1/2 carriers who received textured breast implants as part of breast reconstruction.
This is important information for BRCA1/2 carriers to know about to guide breast reconstruction options, including:
- Those thinking about breast reconstruction options
- Those who already had reconstruction, and have textured implants in place
Read the full article to learn more: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2025016810/537761/BRCA1-2-impact-on-the-development-of-implant
Reference: Ghione et al. Blood Adv. 2025. Online ahead of print. PMID: 40512039.
